Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Advances in Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Geriatric Anorexia – Educational Needs AssessmentRelease Date:Education Internal Medicine USA 2021/2022 Global Cachexia ASPIRERelease Date:Research Internal Medicine All Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for AllergistsRelease Date:Partner: American College of Allergy, Asthma & Immunology (ACAAI)Education Inflammation & Immunology USA Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care PhysiciansRelease Date:Education Inflammation & Immunology USA Pediatric Growth Hormone Deficiency EducationRelease Date:Education Rare Disease USA 2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiencesRelease Date:Research Inflammation & Immunology Italy Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)Release Date:Education Rare Disease All Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New ZealandRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Cardiac Amyloidosis Mentor mATTch pRogramEducation Rare Disease USA Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing RegionsRelease Date:Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA